Dual mechanism of a natural CaMKII inhibitor

被引:154
作者
Vest, Rebekah S. [1 ]
Davies, Kurtis D. [1 ]
O'Leary, Heather [1 ]
Port, J. David [1 ]
Bayer, K. Ulrich [1 ]
机构
[1] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA
关键词
D O I
10.1091/mbc.E07-02-0185
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a major mediator of cellular Call signaling. Several inhibitors are commonly used to study CaMKII function, but these inhibitors all lack specificity. CaM-KIIN is a natural, specific CaMKII inhibitor protein. CN21 (derived from CaM-KIIN amino acids 43-63) showed full specificity and potency of CaMKII inhibition. CNs completely blocked Ca2+-stimulated and autonomous substrate phosphorylation by CaMKII and autophosphorylation at T305. However, T286 autophosphorylation (the autophosphorylation generating autonomous activity) was only mildly affected. Two mechanisms can explain this unusual differential inhibitor effect. First, CNs inhibited activity by interacting with the CaMKII T-site (and thereby also interfered with NMDA-type glutamate receptor binding to the T-site). Because of this, the CaMKII region surrounding T286 competed with CNs for T-site interaction, whereas other substrates did not. Second, the intersubunit T286 autophosphorylation requires CaM binding both to the "kinase" and the "substrate" subunit. CNs dramatically decreased CaM dissociation, thus facilitating the ability of CaM to make T286 accessible for phosphorylation. Tat-fusion made CN21 cell penetrating, as demonstrated by a strong inhibition of filopodia motility in neurons and insulin secrection from isolated Langerhans' islets. These results reveal the inhibitory mechanism of CaM-KIIN and establish a powerful new tool for dissecting CaMKII function.
引用
收藏
页码:5024 / 5033
页数:10
相关论文
共 75 条
[1]   Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions [J].
Aarts, M ;
Liu, YT ;
Liu, LD ;
Besshoh, S ;
Arundine, M ;
Gurd, JW ;
Wang, YT ;
Salter, MW ;
Tymianski, M .
SCIENCE, 2002, 298 (5594) :846-850
[2]   MULTIFUNCTIONAL CA-2+/CALMODULIN-DEPENDENT PROTEIN-KINASE IS NECESSARY FOR NUCLEAR-ENVELOPE BREAKDOWN [J].
BAITINGER, C ;
ALDERTON, J ;
POENIE, M ;
SCHULMAN, H ;
STEINHARDT, RA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (05) :1763-1773
[3]   Regulation of signal transduction by protein targeting: The case for CaMKII [J].
Bayer, KM ;
Schulman, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (05) :917-923
[4]   Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B [J].
Bayer, KU ;
LeBel, E ;
McDonald, GL ;
O'Leary, H ;
Schulman, H ;
De Koninck, P .
JOURNAL OF NEUROSCIENCE, 2006, 26 (04) :1164-1174
[5]   Developmental expression of the CaM kinase II isoforms:: ubiquitous γ- and δ-CaM kinase II are the early isoforms and most abundant in the developing nervous system [J].
Bayer, KU ;
Löhler, J ;
Schulman, H ;
Harbers, K .
MOLECULAR BRAIN RESEARCH, 1999, 70 (01) :147-154
[6]   Alternative splicing modulates the frequency-dependent response of CaMKII to Ca2+ oscillations [J].
Bayer, KU ;
De Koninck, P ;
Schulman, H .
EMBO JOURNAL, 2002, 21 (14) :3590-3597
[7]  
BENNETT MK, 1983, J BIOL CHEM, V258, P2735
[8]   Dependence of insulin secretion from permeabilized pancreatic β-cells on the activation of Ca2+/calmodulin-dependent protein kinase II -: A re-evaluation of inhibitor studies [J].
Bhatt, HS ;
Conner, BP ;
Prasanna, G ;
Yorio, T ;
Easom, RA .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (11) :1655-1663
[9]  
Chan LK, 2001, STAT SINICA, V11, P767
[10]   Characterization of a calmodulin kinase II inhibitor protein in brain [J].
Chang, BH ;
Mukherji, S ;
Soderling, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10890-10895